Predisposition to hematologic malignancies in patients with xeroderma pigmentosum

• Karolyn A. Oetjen,
• Melissa A. Levoska,
• Deborah Tamura,
• Sawa Ito,
• Dorothea Douglas,
• Sikandar G. Khan,
• Katherine R. Calvo,
• Kenneth H. Kraemer,
• John J. DiGiovanna

Affiliations

Karolyn A. Oetjen

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD

Melissa A. Levoska

Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD;Medical Research Scholars Program, NIH, Bethesda, MD

Deborah Tamura

Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD

Sawa Ito

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD

Dorothea Douglas

Division of Hematology/Oncology, Department of Pediatrics, Nemours Children’s Health System, Orlando, FL

Sikandar G. Khan

Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD

Katherine R. Calvo

Department of Laboratory Medicine, NIH Clinical Center, Bethesda, MD, USA

Kenneth H. Kraemer

Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD

John J. DiGiovanna

Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD